STAAR Surgical Company (NASDAQ:STAA) Files An 8-K Regulation FD Disclosure
Item 7.01
| Regulation FD Disclosure. |
Representatives of STAAR Surgical Company will give presentations
to investors on January 10, 2017 and January 11, 2017. A copy of
the slide presentation they will use in their presentations is
furnished as Exhibit 99.1 to this Report, and is incorporated
herein by this reference.
The information furnished herewith to Item 7.01 of this Current
Report, including Exhibit 99.1, shall not be deemed to be filed
for the purposes of Section 18 of the Securities Exchange Act of
1934, as amended (the Exchange Act), or otherwise subject to the
liabilities of that section. The information in Item 7.01 of this
Current Report shall not be incorporated by reference into any
filing under the Securities Act of 1933, as amended, or the
Exchange Act, whether made before or after the date of this
Current Report, regardless of any general incorporation language
in the filing.
| Item 9.01 | Financial Statements and Exhibits |
| (d) | Exhibits |
| Exhibit No. | Description |
| 99.1 | Slide Presentation dated January 10-11, 2017. |
About STAAR Surgical Company (NASDAQ:STAA)
STAAR Surgical Company designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The Company operates in the ophthalmic surgical market segment. Its principal products are intraocular lenses (IOLs) used in cataract surgery and implantable collamer lenses (ICLs) used in refractive surgery. It makes lenses used across the world in corrective or refractive surgery, and makes lenses for use in surgery that treats cataracts. Its refractive surgery corrects the types of visual disorders that glasses or contact lenses have treated (myopia, hyperopia, astigmatism and presbyopia). Its refractive surgery corrects the types of visual disorders that glasses or contact lenses have treated (myopia, hyperopia, astigmatism and presbyopia). It sells its products in approximately 60 countries, with direct distribution in the United States, Canada, Japan and Spain, and independent distribution in the remainder of the world. STAAR Surgical Company (NASDAQ:STAA) Recent Trading Information
STAAR Surgical Company (NASDAQ:STAA) closed its last trading session down -0.10 at 10.70 with 112,570 shares trading hands.
